Paden brings to this position over 20 years of diverse experience in clinical research, including operational and scientific leadership roles, clinical trial management and monitoring, publication planning, product lifecycle management, and clinical training and education.
At Prometrika, Paden will lead clinical operations in day-to-day trial management activities and in the development of systems and procedures to further enhance the company's delivery of clinical research.
Paden's leadership roles have included head of clinical development operations at ContraFect Corp., senior consultant at Halloran Consulting, and director of clinical development medical affairs at Boehringer Ingelheim Pharmaceuticals.
Her work has covered orphan indications in oncology, cardiovascular disease, and genetic disorders.
Founded in 2003 and based in Cambridge, Massachusetts, Prometrika utilises a collaborative approach to clinical development and execution with a close-knit, highly-experienced senior leadership team involved in all phases of trials.
Prometrika's services include complete clinical operations and clinical trial management, data management, pharmacovigilance, biostatistics and programming, medical writing, and regulatory submissions.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business